► Customized research for MLNT vs. KLYG!
► All in one page research, scroll down. Compare two other stocks.
► Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
Done! Side by Side Research Below for MLNT vs. KLYG.
↗ Join Our Free Email Newsletter.
► Melinta Therapeutics Inc. vs. Kelyniam Global, Inc.
Industry Match! Industry of Both MLNT and KLYG:
Health Care/Life Sciences
MLNT
Data Last Updated: More than 3 wks ago
↻ Update Column 1 to Most Recent
► Key Statistics
Cap: 27.614M
P/E: N/A
P/S: 0.29
Q P/B: 0.19
Y Rev: 96.43M
Q Rev: 15.96M
Beta: 7.14

MLNT Share Stats
► Outstanding Shares
11.78M
► Float Shares
10.37M
► Percent of Float Short
19.93%
MLNT Insider Stats
► Percent Outstanding Insider Ownership
N/A
► Percent Outstanding Institution Ownership
N/A
MLNT Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share MLNT Insights
MLNT Profile
► CEO
Ms. Jennifer A. Sanfilippo
► Exchange
Nasdaq
► Employees
290.00
► About
Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv,...

MLNT Financials
Annual Financials
Income Statement
► Revenue
96.43M
► Net Income
(157.19M)
Cash Flow Statement
► Change in Cash / Investments
(46.58M)
Balance Sheet
► Cash / Investments
81.81M
► Short Term Debt
None
► Long Term Debt
110.48M
► Total Current Assets
149.48M
► Total Current Liabilities
133.61M
► Total Assets
441.59M
► Total Liabilities
251.53M
► Stockholder Equity
190.06M
Quarterly Financials
Income Statement
► Q Revenue
15.96M
► Q Net Income
(36.18M)
Cash Flow Statement
► Q Change in Cash / Investments
(26.56M)
Balance Sheet
► Q Cash / Investments
90.34M
► Q Short Term Debt
13.79M
► Q Long Term Debt
157.06M
► Q Total Current Assets
156.76M
► Q Total Current Liabilities
132.39M
► Q Total Assets
440.37M
► Q Total Liabilities
298.71M
► Q Stockholder Equity
141.67M

MLNT Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

KLYG
Data Last Updated: More than 2 wks ago
↻ Update Column 2 to Most Recent
► Key Statistics
Cap: 2.05M
P/E: N/A
P/S: 0.97
Q P/B: 4.88
Y Rev: 2.12M
Q Rev: 394,694
Beta: 2.28

KLYG Share Stats
► Outstanding Shares
12.60M
► Float Shares
2.73M
► Percent of Float Short
N/A
KLYG Insider Stats
► Percent Outstanding Insider Ownership
N/A
► Percent Outstanding Institution Ownership
N/A
KLYG Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share KLYG Insights
KLYG Profile
► CEO
Mr. Ross Bjella
► Exchange
OTC
► Employees
N/A
► About
Kelyniam Global, Inc. operates as a medical device manufacturing company, which engages in the production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers. The company was founded on December 30,...

KLYG Financials
Annual Financials
Income Statement
► Revenue
2.12M
► Net Income
(15,304)
Cash Flow Statement
► Change in Cash / Investments
(99,891)
Balance Sheet
► Cash / Investments
66,429
► Short Term Debt
136,758
► Long Term Debt
219,166
► Total Current Assets
407,764
► Total Current Liabilities
429,999
► Total Assets
1.25M
► Total Liabilities
649,165
► Stockholder Equity
604,671
Quarterly Financials
Income Statement
► Q Revenue
394,694
► Q Net Income
(181,483)
Cash Flow Statement
► Q Change in Cash / Investments
(641)
Balance Sheet
► Q Cash / Investments
35,566
► Q Short Term Debt
191,123
► Q Long Term Debt
263,300
► Q Total Current Assets
299,261
► Q Total Current Liabilities
456,622
► Q Total Assets
1.14M
► Q Total Liabilities
719,922
► Q Stockholder Equity
420,104

KLYG Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

